Precision for Medicine has appointed former US FDA senior adviser Dr Vicki Seyfert-Margolis to the role of chief of science and strategy.
Dr Seyfert-Margolis served as senior adviser, regulatory science and innovation at the US regulator, reporting directly to the commissioner.
During this time, she led the FDA’s regulatory science and personalised medicine initiative, as well as strategies for promoting innovation in drug development.
Prior to her time with the FDA, Dr Seyfert-Margolis was chief science officer at the Immune Tolerance Network, a global research initiative to discover biomarkers for autoimmune disorders.
In her new role at Precision for Medicine, which provides research support to life science companies, Dr Syfert-Margolis will guide the company’s scientific strategy and provide insight and support for its clients.
“Precision for Medicine shares my vision for the future of healthcare – one where the patient is not just the end user, but the focal point of all aspects of drug, diagnostic, and device development,” said Dr Seyfert-Margolis.